Bharat Biotech not allowed to conduct simultaneous Phase I, II trials for its intranasal COVID-19 vaccine – Moneycontrol

Bharat Biotech not allowed to conduct simultaneous Phase I, II trials for its intranasal COVID-19 vaccine  MoneycontrolView Full coverage on Google News